Büşra Aydın

462 total citations
24 papers, 354 citations indexed

About

Büşra Aydın is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Büşra Aydın has authored 24 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Büşra Aydın's work include Pituitary Gland Disorders and Treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Amyotrophic Lateral Sclerosis Research (2 papers). Büşra Aydın is often cited by papers focused on Pituitary Gland Disorders and Treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Amyotrophic Lateral Sclerosis Research (2 papers). Büşra Aydın collaborates with scholars based in Türkiye, Australia and Bangladesh. Büşra Aydın's co-authors include Kazım Yalçın Arğa, Medi Kori, Semra Ünal, Dilek Kazan, Tania Islam, Md Rezanur Rahman, Md. Shahjaman, Ayşe Serap Karadağ, Tuğba Özer and Ebru Toksoy Öner and has published in prestigious journals such as European Journal of Immunology, European Journal of Pharmacology and Medicine.

In The Last Decade

Büşra Aydın

22 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Büşra Aydın Türkiye 9 143 67 56 51 47 24 354
Huimin Cao China 14 264 1.8× 86 1.3× 44 0.8× 52 1.0× 10 0.2× 25 475
Lijun Dai China 13 153 1.1× 95 1.4× 69 1.2× 25 0.5× 76 1.6× 30 470
Mohammad Taghi Akbari Iran 12 170 1.2× 57 0.9× 45 0.8× 22 0.4× 20 0.4× 57 492
Rodrigo Bertollo de Alexandre Brazil 8 277 1.9× 57 0.9× 34 0.6× 13 0.3× 62 1.3× 13 437
Huanhai Liu China 12 257 1.8× 91 1.4× 56 1.0× 13 0.3× 26 0.6× 48 487
Liang Fan China 11 281 2.0× 36 0.5× 18 0.3× 53 1.0× 16 0.3× 14 457
Xiangjun Zeng China 7 130 0.9× 55 0.8× 28 0.5× 14 0.3× 14 0.3× 18 348
Zhen He China 10 217 1.5× 17 0.3× 70 1.3× 80 1.6× 21 0.4× 25 454
Gengyun Sun China 15 321 2.2× 98 1.5× 42 0.8× 14 0.3× 20 0.4× 35 519

Countries citing papers authored by Büşra Aydın

Since Specialization
Citations

This map shows the geographic impact of Büşra Aydın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Büşra Aydın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Büşra Aydın more than expected).

Fields of papers citing papers by Büşra Aydın

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Büşra Aydın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Büşra Aydın. The network helps show where Büşra Aydın may publish in the future.

Co-authorship network of co-authors of Büşra Aydın

This figure shows the co-authorship network connecting the top 25 collaborators of Büşra Aydın. A scholar is included among the top collaborators of Büşra Aydın based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Büşra Aydın. Büşra Aydın is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Başaran, Özge, Erdal Sağ, Büşra Aydın, et al.. (2025). Lack of HLH in FMF. Pediatric Rheumatology. 23(1). 14–14.
2.
Evirgen, Şehrazat, et al.. (2024). Intake of probiotics as an option for reducing oral and prosthetic microbiota: A clinical study. Journal of Prosthetic Dentistry. 133(5). 1276.e1–1276.e8. 1 indexed citations
3.
Akça, Ümmüşen Kaya, Erdal Sağ, Büşra Aydın, et al.. (2023). Chronic non-bacterial osteomyelitis and immune checkpoint molecules. Clinical Rheumatology. 43(1). 553–560.
4.
Kori, Medi, et al.. (2022). Prospects of integrated multi-omics-driven biomarkers for efficient hair loss therapy from systems biology perspective. Gene Reports. 28. 101657–101657. 2 indexed citations
5.
Şendur, Süleyman Nahit, Büşra Aydın, İncilay Lay, et al.. (2022). Reduced irisin levels in patients with acromegaly. Hormone Molecular Biology and Clinical Investigation. 43(3). 251–261. 3 indexed citations
6.
Aydın, Büşra, Kazım Yalçın Arğa, Betül Karademir, et al.. (2022). Past, Present, and Future of Therapies for Pituitary Neuroendocrine Tumors: Need for Omics and Drug Repositioning Guidance. OMICS A Journal of Integrative Biology. 26(3). 115–129. 2 indexed citations
7.
Aydın, Büşra, et al.. (2022). Integrative Analysis of Motor Neuron and Microglial Transcriptomes from SOD1G93A Mice Models Uncover Potential Drug Treatments for ALS. Journal of Molecular Neuroscience. 72(11). 2360–2376. 7 indexed citations
8.
Aydın, Büşra, et al.. (2022). Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors. Journal of Endocrinological Investigation. 46(4). 727–747. 6 indexed citations
10.
Aydın, Büşra, et al.. (2021). Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies. The EPMA Journal. 12(3). 383–401. 10 indexed citations
11.
Aydın, Büşra, et al.. (2021). MicroRNA-Mediated Drug Repurposing Unveiled Potential Candidate Drugs for Prolactinoma Treatment. Neuroendocrinology. 112(2). 161–173. 8 indexed citations
12.
Alikaşifoğlu, Ayfer, Nurgün Kandemir, Büşra Aydın, et al.. (2020). Novel insights into diabetes mellitus due to DNAJC3 defect: Evolution of neurological and endocrine phenotype in the pediatric age group. Pediatric Diabetes. 21(7). 1176–1182. 8 indexed citations
13.
Aydın, Büşra, Kazım Yalçın Arğa, & Ayşe Serap Karadağ. (2020). <p>Omics-Driven Biomarkers of Psoriasis: Recent Insights, Current Challenges, and Future Prospects</p>. Clinical Cosmetic and Investigational Dermatology. Volume 13. 611–625. 20 indexed citations
14.
Islam, Tania, et al.. (2020). Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19. European Journal of Pharmacology. 887. 173594–173594. 54 indexed citations
15.
Tavukçuoğlu, Ece, Utku Horzum, Hamdullah Yanık, et al.. (2020). Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer. European Journal of Immunology. 50(12). 2067–2074. 36 indexed citations
16.
Bircan, Rıfat, Aylin Gül, Büşra Aydın, et al.. (2019). BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure. Endokrynologia Polska. 70(5). 401–408. 6 indexed citations
17.
Erol, Timüçin, et al.. (2019). Primary tumor resection for initially staged IV breast cancer. Medicine. 98(33). e16773–e16773. 9 indexed citations
18.
Aydın, Büşra & Kazım Yalçın Arğa. (2019). Co-expression Network Analysis Elucidated a Core Module in Association With Prognosis of Non-functioning Non-invasive Human Pituitary Adenoma. Frontiers in Endocrinology. 10. 361–361. 25 indexed citations
19.
Aydın, Büşra, Tuğba Özer, Ebru Toksoy Öner, & Kazım Yalçın Arğa. (2018). The Genome-Based Metabolic Systems Engineering to Boost Levan Production in a Halophilic Bacterial Model. OMICS A Journal of Integrative Biology. 22(3). 198–209. 14 indexed citations
20.
Kori, Medi, Büşra Aydın, Semra Ünal, Kazım Yalçın Arğa, & Dilek Kazan. (2016). Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. OMICS A Journal of Integrative Biology. 20(11). 645–661. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026